‘Living Drug’ That Fights Cancer By Harnessing Immune System Clears Key Hurdle

A Food and Drug Administration advisory committee unanimously recommended that the agency approve this “living drug” approach for children and young adults who are fighting a common form of leukemia. The agency doesn’t have to follow the committee’s recommendation but usually does.